000			02175cam a2200301zu 4500
001			88963116
003			FRCYB88963116
005			20250429180909.0
006			m o d
007			cr un
008			250429s2019 fr | o|||||0|0|||eng d
020			_a9780128167731
035			_aFRCYB88963116
040			_aFR-PaCSA _ben _c _erda
100	1		_aShah, Muhammad Raza
245	0	1	_aNanocarriers for Cancer Diagnosis and Targeted Chemotherapy _c['Shah, Muhammad Raza', 'Imran, Muhammad', 'Ullah, Shafi']
264		1	_bElsevier Science _c2019
300			_a p.
336			_btxt _2rdacontent
337			_bc _2rdamdedia
338			_bc _2rdacarrier
650		0	_a
700	0		_aShah, Muhammad Raza
700	0		_aImran, Muhammad
700	0		_aUllah, Shafi
856	4	0	_2Cyberlibris _uhttps://international.scholarvox.com/netsen/book/88963116 _qtext/html _a
520			_aNanocarriers for Cancer Diagnosis and Targeted Chemotherapy reviews the principles and applications of nanocarriers for targeted drug delivery. Drug targeting involves active and passive strategies that exploit both the use of ligands for interactions and the physical and chemical properties of nanocarriers and micro-environments at target sites. Multidrug resistance and adverse side effects associated with anticancer drugs have attracted greater scientific attention and led formulation scientists to specifically target these drugs to target sites. Nanocarriers like liposomes, niosomes, gold nanorods, carbon nanotubes, and micelles are discussed for the delivery of drugs to specific disease sites. This is an important reference source for researchers in the biomedical and biomaterials fields who want to gain an understanding on how nanotechnology is used for earlier diagnoses and more effective cancer treatment. - Explores the fundamental principles of drug targeting through different nano-carriers, highlighting major applications - Shows how the use of nanocarriers is leading to quicker cancer diagnosis and more effective treatment - Discusses the major challenges of using nanocarriers for drug delivery and assesses how to overcome these barriers
999			_c1323511 _d1323510